Insider · CIK 0001342502
Jane Buchan
Files at GL (GLOBE LIFE INC.), IMMX (Immix Biopharma, Inc.). First filing Dec 13, 2023, latest Dec 13, 2023.
In brief
Jane Buchan files SEC Form 4 as director at GL (GLOBE LIFE INC.), and also at IMMX (Immix Biopharma, Inc.). Since Dec 13, 2023, Jane Buchan has reported 0 open-market buys worth $0 and 1 open-market sell worth $125k, the latest filed on Dec 13, 2023.
A track record needs three past buys with six months of prices behind them; Jane Buchan has 0, so none is measured yet.
The newest scored trade: sold $125k of GL on Dec 12, 2023, filed Dec 13, 2023, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GL: GLOBE LIFE INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | GLOBE LIFE INC. | $125k 1,000 shares | -1% | +21% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 12, 2023 | GL GLOBE LIFE INC. | 1,000 0.00% of outstanding | $124k | Dec 12, 2023 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Common Stock | +6,250 | $0.00 | $0 | 28,705 | May 29, 2026 |
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | May 29, 2026 |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +33,000 | $0.00 | $0 | 33,000 | Jun 23, 2025 |
| Jan 2, 2024 | GL GLOBE LIFE INC. | AGrant or award Director Stock Option (Right to Buy)derivative | +1,728 | $0.00 | $0 | 1,728 | Jan 3, 2024 |
| Dec 12, 2023 | GL GLOBE LIFE INC. | SOpen-market sale Common Stock | -1,000 | $124.50 | $125k | 80,285 | Dec 13, 2023 |
| Nov 21, 2023 | GL GLOBE LIFE INC. | GGift Common Stock | -10 | $0.00 | $0 | 81,285 | Nov 22, 2023 |
| Nov 16, 2023 | GL GLOBE LIFE INC. | GGift Common Stock | -425 | $0.00 | $0 | 81,295 | Nov 17, 2023 |
Questions about Jane Buchan
Answered from the filings on this page, as of the latest one.
Is Jane Buchan buying or selling?
Not in the last 12 months. Jane Buchan's latest open-market trade on SEC Form 4 was sold $125k of GL on Dec 12, 2023.
How did Jane Buchan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jane Buchan has 0.
Where does Jane Buchan file Form 4?
Jane Buchan has filed Form 4 at GL (GLOBE LIFE INC.); IMMX (Immix Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.